Conference Menu

Overview
Track 1: Health Economics of Genomic Medicine
Track 2: Reimbursement of Molecular Diagnostics
Register
Short Courses
Sponsor & Exhibit
Hotel & Travel
PDF Download 

Press Pass
Request Brochure 

Archives 

Media Partners 

Bentham Science Logo 

Bio-IT World Large 

Clinical Informatics News 

Genetic Engineering News 

Genomeweb Logo 

Insight Pharma Reports 

Nature_logo 

Pharmaphorum 

PharmaVoice 

Science AAAS 

The Scientist 


Evidence Based Reimbursement Summit


Now Accepting Speaker Proposals

Submit your proposal by April 18 for priority consideration 

Genomic medicine, genome-guided prevention and treatment of complex diseases, is becoming a reality due to the latest achievements in genome research as well as the clinical implementation of powerful technologies such as massively parallel sequencing and digital PCR. The bottleneck of this innovation coming into clinical practice is the current reimbursement uncertainty. The combination of tightening healthcare budgets and the launch of a large number of expensive molecular tests as well as pricey targeted therapies creates complications for payers to respond in traditional ways. The Third Annual Evidence-Based Reimbursement Summit is designed to bring together major stakeholders from pharmaceutical, biotech, IVD companies, laboratory medicine community and healthcare providers community to exchange opinions and to search for solutions in the innovative medicine commercialization equation.

Track 1:  Health Economics of Genomic Medicine

Measuring the Impact of Next-Generation Sequencing   
November 17-18, 2014

The topics to be covered include but are not limited to:

  • Health economics of precision medicine
  • Integrating payer’s perspective into targeted therapies development
  • Validating biomarkers while providing patient care
  • Matching evidentiary requirements of regulators, payers and healthcare professionals
  • Comparative effectiveness research in genomic medicine
  • Use of genomics for optimizing therapy costs
  • Value-based pricing in oncology and other therapeutic areas
  • Establishing the value of a genomic/pharmacogenomic test 
  • Clinical trials for stand-alone and companion diagnostics
  • Impact of companion assay reimbursement on the drug market access
  • N-of-1 trials: new paradigm in clinical research?
  • Simulation clinical trials
  • Patient as a consumer/decision maker in the era of genomic medicine

Track 2: Reimbursement of Molecular Diagnostics

Partnering with Payers, Healthcare Centers and KOLs  
November 18-19, 2014

The topics to be covered include but are not limited to:

  • Molecular diagnostic technology assessment
  • Strategies to engage payers in diagnostic technology assessment
  • Winning investigational programs
  • Clinical need and clinical utility in molecular diagnostics
  • Working with national guidelines task force expertsReimbursement of cancer genomic analysis
  • Reimbursement of NGS assays
  • Reimbursement of standalone vs. companion diagnostics
  • CPT code update
  • Medical affairs at work: provider is the key
  • Working with government and private payers: case studies
  • Academic center’s experience with billing and reimbursement

Experts who wish to give a podium presentation are encouraged to submit a proposal based on their work in the area of commercialization of targeted therapies and/or molecular diagnostics. Please remember to specify the conference you are interested in and to provide your full contact information.

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. 

If you are interested in presenting, please click here to submit a speaking proposal for review.

Deadline for submission is April 18, 2014. 

We truly welcome your comments, suggestions and speaker referrals as we shape the program. 

For more details on the conference, please contact: 

Marina Filshtinsky, M.D.
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5496
Email: mfilshtinsky@healthtech.com

For exhibit & sponsorship information, please contact: 

Joseph Vacca
Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5431
Mobile: (+1) 617-224-7173
Fax:(+1) 781-972-5470
Email: jvacca@healthtech.com 

For media and partnership opportunities, please contact:

Pete DeOlympio
Marketing Manager
Cambridge Healthtech Institute
Phone: 781-972-5415
Email: peted@healthtech.com 



By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs